13F Pro Quality Score

74.2/100

Rank #117 of 2,961 stocksTOP 5%

View Industrials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

91.7/100

Profitability

79.9/100

Balance Sheet

74.8/100

Earnings Quality

89.8/100

Free Cash Flow

98.6/100

Institutional Flow

82.7/100

Revenue Scale

15.8/100

Dilution Risk

24.3/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Unusual Activity in PAYS

Events flagged as statistical outliers against PAYS's own multi-year baseline — not fixed dollar thresholds.

PAYS Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Paysign, Inc. (PAYS), a Industrials sector company. 13F Pro's AI-powered ranking engine scores PAYS at 74.2/100 on a 32-signal composite quality model, placing it at rank #117 of 2,961 stocks — the top 5% of the AI-ranked universe. PAYS scores in the top quartile across free cash flow (98.6), revenue growth (91.7), earnings quality (89.8). Areas of concern include revenue scale (15.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 24.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Paysign, Inc. reports quarterly revenue of $28.3M, net income of $6.8M, free cash flow of $1.2M. Top institutional holders of PAYS by reported 13-F value include Topline Capital Management, BlackRock, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, based on the most recent SEC filings. PAYS trades on the Nasdaq exchange and files with the SEC under CIK 1496443. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PAYS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Paysign, Inc. directly from SEC EDGAR. Paysign, Inc.'s 13F Pro composite quality score has ranged between 22 and 74 since 2022, currently 74.2 — an improving long-term trajectory across 64 quarterly and live scoring snapshots.

Fun facts about Paysign, Inc.

Quirks, history, and lore behind PAYS — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. financial technology company · small-cap · listed on Nasdaq · headquartered in Nevada.
  • 2
    The Numbers
    Annual revenue in the range of tens of millions of dollars — not a giant, but a profitable niche player in the prepaid debit card processing space.
  • 3
    The History
    Founded in the late 1990s, the company grew by targeting industries that the traditional banking world largely ignored or underserved.
  • 4
    The Secret
    Its bread and butter is administering prepaid card programs for tribal gaming casinos and pharmaceutical patient-assistance programs — a very specific lane.
  • 5
    The Lore
    It built a loyal foothold by helping casino patrons access cash and winnings without ever touching a traditional bank account — ATM lines at Vegas get very long.
  • 6
    The Giveaway
    Its ticker is literally a four-letter synonym for getting paid, and its whole business is making sure people — from casino floors to pharmaceutical patients — can collect their money on a card.
▶ Think you know your stocks? Play the Daily Ticker

What's Driving PAYS's Business? Latest 10-Q Breakdown

34/34 datapoints verified

AI-extracted from Paysign, Inc.'s 10-Q filed 2026-08-06 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Q2 revenue rose 48.1% to $28.3M as pharma patient affordability revenue nearly doubled to $14.6M, lifting net income to $6.8M from $1.4M.

Biggest Revenue Drivers

Pharma industry$14.6M+88.9% YoY

Financial benefit of 51 net pharma patient affordability programs launched in the prior twelve months and higher management, setup and claim processing fees

Plasma industry$13.0M+21.4% YoY

Increase in plasma donations and dollars loaded to cards as the market returned to normalized growth, offset by 46 net plasma center reductions

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Revenue

Q2 2026

$28.3M

Net Income

Q2 2026

$6.8M

Free Cash Flow

Q2 2026

$1.2M

ROIC

Q2 2026

42.9%

D/E Ratio

Q2 2026

0.09

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+40.5% YoY
$82.0MFY 2025
FY22 $38.0MFY23 $47.3MFY24 $58.4MFY25 $82.0M

Net Income

+97.9% YoY
$7.6MFY 2025
FY22 $1.0MFY23 $6.5MFY24 $3.8MFY25 $7.6M

Operating Income

+620.8% YoY
$7.4MFY 2025
FY22 $344.3KFY23 $-167.3KFY24 $1.0MFY25 $7.4M

EPS (Diluted)

+85.7% YoY
$0.13FY 2025
FY22 $0.02FY23 $0.12FY24 $0.07FY25 $0.13

Total Assets

+54.3% YoY
$276.3MFY 2025
FY22 $108.2MFY23 $146.6MFY24 $179.0MFY25 $276.3M

Total Debt

$8.0MFY 2025
FY22 FY23 FY24 $0.00FY25 $8.0M

Op. Cash Flow

+128.6% YoY
$52.5MFY 2025
FY22 $25.3MFY23 $27.6MFY24 $22.9MFY25 $52.5M

Free Cash Flow

+127.6% YoY
$51.2MFY 2025
FY22 $25.2MFY23 $27.4MFY24 $22.5MFY25 $51.2M

Get alerted when PAYS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Paysign, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Companies Similar to PAYS

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

LQDT

LIQUIDITY SERVICES INC

64
AI score
Similar quality profile · 3 shared holders
RCMT

RCM TECHNOLOGIES, INC.

53
AI score
Similar quality profile · 3 shared holders
RSSS

Research Solutions, Inc.

46
AI score
Similar quality profile · 5 shared holders
HQY

HEALTHEQUITY, INC.

71
AI score
Similar quality profile
PKE

PARK AEROSPACE CORP

62
AI score
Similar quality profile · 3 shared holders
FLYW

Flywire Corp

67
AI score
Similar quality profile · 2 shared holders
LOAR

Loar Holdings Inc.

65
AI score
Similar quality profile

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put PAYS on your watchlist

Track score changes the day Paysign, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is PAYS a good stock to buy?

13F Pro's AI-powered analysis of Paysign, Inc. (PAYS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PAYS are available on the PAYS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. PAYS is classified as a small company.

Which hedge funds own PAYS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PAYS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Paysign, Inc.'s investment landscape.